Know When to Use a GLP-1 Agonist or SGLT2i First-Line

February 2023

You’ll hear debate about whether metformin should still be first-line for all patients with type 2 diabetes.

It continues to be the gold standard for most patients based on its established efficacy and safety...and low cost.

Metformin also has possible CV benefits...and can be used in patients with eGFR down to 30 mL/min/1.73 m².

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote